Terms ending in 2032
Every in-force patent on AstraZeneca AB's record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,895,570 | Purine Derivatives In force · High confidence | Sumitomo Pharma Co., Ltd. | In force | High confidence | |
| US 9,402,847 | Combinations Comprising (S)-4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 8,748,603 | Crystalline Forms of N-[2-[[(2,3-Difluorophenyl)METHYL]THIO]-6-{[(1R,2S)-2,3-Dihydroxy-1-Methylpropyl]OXY}-4-Pyrimidinyl]-1-Azetidinesulfonamide In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 9,079,873 | Process for the Preparation of Benzyl [(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol]-4-yl]carbamate and Intermediates in the Process In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 8,894,970 | Arginase Inhibitors and Methods of Use Thereof In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 9,732,058 | 2-(2,4,5-Substituted-ANILINO)PYRIMIDINE Compounds In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 10,017,493 | 2-(2,4,5-Substituted-ANILINO)PYRIMIDINE Compounds In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 10,858,336 | 2-(2,4,5-Substituted-ANILINO)PYRIMIDINE Compounds In force · Medium confidence | AstraZeneca AB | In force | Medium confidence | |
| US 11,524,951 | 2-(2,4,5-Substituted-ANILINO)PYRIMIDINE Compounds In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 8,771,648 | (TRIMETHOXYPHENYLAMINO) Pyrimidinyl Formulations In force · High confidence | Rigel Pharmaceuticals, Inc. | In force | High confidence | |
| 8 more term ends in 2032 · Pro | |||||
10 of 18 patents shown. Soonest term end first, then patent number.
Pro members see all 18.
13 of these are in force and held by AstraZeneca AB.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.